What an amazing journey. As we celebrate our 2 year anniversary I wanted to share a few thoughts with our customers, supporters and patients. The fact that we're still here shows that you have all helped in our success.
Everyday we are touched by all the amazing stories we hear from our patients. We are treating soldiers, firemen, police officers and everyday people who just want to finish the marathon. We get emails and phone calls thanking us for finally treating ailments that have bothered them for years. Treating with the AcuKnee when nothing else worked. What our patients don't know, we get a greater pleasure every time we hear these success stories. We hear patients tell us that they were skeptics at first, but were pleasantly surprised by how much better they feel after treating with our products.
As we continue to grow and venture into the next steps of our business, I wanted to thank all of you for all the support you've given us.
Happy Holidays
The AcuKnee Team.
http://www.acuknee.com
P.S. Check out our new website design, hopefully this will make the experience much better.
AcuKnee Knee Osteoarthritis treatment system updates. Developments in Knee OA Treatments.
Thursday, November 28, 2013
Monday, November 11, 2013
Thanks to all of our nations Veterans. As a thanks AcuKnee.com would like to offer a 25% off promotion using the promo code Vet25.
www.acuknee.com
www.acuknee.com
Friday, November 8, 2013
How it Works
The
AcuKnee™ system utilizes the latest research and technology surrounding
the use of electrotherapy for treating pain associated with a variety
of knee ailments. The AcuKnee™ treatment works by inhibiting your
bodies natural healing mechanisms to relieve pain and reduce
inflammation. Using precision electrode placement and the proprietary
Pain Warrior frequency sequencing, the AcuKnee™ sends small electrical
impulses through the spinal cord and ultimately to the brain. This treatment
process suppresses interleukin-1 (IL-1), which is the cytokine that
plays a central role in the regulation of immune and inflammatory
responses. In addition, the AcuKnee releases endorphins, stimulates the
Peri-aquaductal grey area of the brain and acts on pain receptors to
reduce and possibly eliminate knee pain.
AcuKnee™ patients on average, experience a 50% pain reduction based on the scoring results from the KOOS outcome test. In addition to providing immediate short and long term pain relief, the Acuknee™ will reduce swelling in the knee, which has been shown in our studies to slow, and in some cases halt, the progression of knee osteoarthritis. AcuKnee™ is Precision electrotherapy intended for the treatment of knee osteoarthritis, knee pain, athlete recovery, knee overuse and non-surgical athletic injuries of the knee. The AcuKnee system is currently used by orthopedic surgeons, physical therapists, athletic trainers and sports medicine specialists around the world. After nearly 2 years on the market, the AcuKnee™ system has less than a 1% return rate. We offer a industry leading 3 year warranty and a limited 30 day risk free trial. If after using the AcuKnee™ for less than 30 days and you’re not satisfied with the results, feel free to return your product for a refund.
The AcuKnee™ is the first and only device of its kind cleared by the FDA and available over the counter(OTC) without a prescription.
Acuknee™ with NMES is the future of non-surigical knee care.
www.acuknee.com
AcuKnee™ patients on average, experience a 50% pain reduction based on the scoring results from the KOOS outcome test. In addition to providing immediate short and long term pain relief, the Acuknee™ will reduce swelling in the knee, which has been shown in our studies to slow, and in some cases halt, the progression of knee osteoarthritis. AcuKnee™ is Precision electrotherapy intended for the treatment of knee osteoarthritis, knee pain, athlete recovery, knee overuse and non-surgical athletic injuries of the knee. The AcuKnee system is currently used by orthopedic surgeons, physical therapists, athletic trainers and sports medicine specialists around the world. After nearly 2 years on the market, the AcuKnee™ system has less than a 1% return rate. We offer a industry leading 3 year warranty and a limited 30 day risk free trial. If after using the AcuKnee™ for less than 30 days and you’re not satisfied with the results, feel free to return your product for a refund.
The AcuKnee™ is the first and only device of its kind cleared by the FDA and available over the counter(OTC) without a prescription.
Acuknee™ with NMES is the future of non-surigical knee care.
www.acuknee.com
Wednesday, November 6, 2013
Abstract
Knee osteoarthritis
(OA) is associated with quadriceps atrophy and weakness, so muscle
strengthening is an important point in the rehabilitation process. Since
pain and joint stiffness make it often difficult to use conventional
strength exercises, neuromuscular electrical stimulation (NMES) may be
an alternative approach for these patients. This study was aimed at (1)
identifying the associations of knee OA with quadriceps muscle
architecture and strength, and (2) quantifying the effects of a NMES
training program on these parameters. In phase 1, 20 women with knee OA
were compared with 10 healthy female, asymptomatic, age-matched control
subjects. In phase 2, 12 OA patients performed an 8-week NMES strength
training program. OA patients presented smaller vastus lateralis
thickness (11.9 mm) and fascicle length (20.5%) than healthy subjects
(14.1 mm; 24.5%), and also had a 23% smaller knee extensor torque
compared to the control group. NMES training increased vastus lateralis
thickness (from 12.6 to 14.2 mm) and fascicle length (from 19.6% to
24.6%). Additionally, NMES training increased the knee extensor torque
by 8% and reduced joint pain, stiffness, and functional limitation. In
conclusion, OA patients have decreased strength, muscle thickness, and
fascicle length in the knee extensor musculature compared to control
subjects. NMES training appears to offset the changes in quadriceps
structure and function, as well as improve the health status in patients
with knee OA.
Copyright © 2012 Orthopaedic Research Society.
www.acuknee.com
Copyright © 2012 Orthopaedic Research Society.
www.acuknee.com
Subscribe to:
Posts (Atom)